4-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-2-[[1-(morpholinomethyl)cyclopropyl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-5-methyl-naphthalen-2-ol

ID: ALA4857517

PubChem CID: 156405063

Max Phase: Preclinical

Molecular Formula: C33H42N6O3

Molecular Weight: 570.74

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc2cc(O)cc(N3CCc4c(nc(OCC5(CN6CCOCC6)CC5)nc4N4CC5CCC(C4)N5)C3)c12

Standard InChI:  InChI=1S/C33H42N6O3/c1-22-3-2-4-23-15-26(40)16-29(30(22)23)38-10-7-27-28(19-38)35-32(36-31(27)39-17-24-5-6-25(18-39)34-24)42-21-33(8-9-33)20-37-11-13-41-14-12-37/h2-4,15-16,24-25,34,40H,5-14,17-21H2,1H3

Standard InChI Key:  FCEQDHUJBGSRCC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 42 49  0  0  0  0  0  0  0  0999 V2000
   19.8809   -5.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4764   -5.7121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2934   -5.7074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6448   -5.7189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3545   -5.3095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3517   -4.4868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6431   -4.0815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9368   -5.3099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9409   -4.4904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2371   -4.0793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5247   -4.4832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5206   -5.3028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2289   -5.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6418   -3.2670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3497   -2.8569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3485   -2.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6410   -1.6336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9331   -2.0437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9327   -2.8635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8144   -5.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1089   -5.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3992   -5.6960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3938   -6.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8108   -6.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1054   -6.9230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1020   -7.7331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8033   -8.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5094   -7.7348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5093   -6.9261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0629   -5.7169    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6942   -5.2828    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2174   -6.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1829   -2.6621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0166   -2.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7699   -5.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4795   -6.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7725   -6.9416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0688   -6.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3639   -6.9385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3609   -7.7560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0691   -8.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7803   -7.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  8  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  7 14  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 25  1  0
 24 20  1  0
 12 20  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 24  2  0
  5 30  1  0
 22 31  1  0
 29 32  1  0
 18 33  1  0
 33 34  1  0
 34 16  1  0
 30 35  1  0
 35  2  1  0
  2 36  1  0
 36 37  1  0
 37 38  1  0
 37 42  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4857517

    ---

Associated Targets(Human)

A-427 (643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KRAS Tclin GTPase KRas (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 570.74Molecular Weight (Monoisotopic): 570.3318AlogP: 3.64#Rotatable Bonds: 7
Polar Surface Area: 86.22Molecular Species: BASEHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.33CX Basic pKa: 9.96CX LogP: 4.05CX LogD: 2.43
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.44Np Likeness Score: -0.26

References

1. Kargbo RB..  (2021)  Targeting the KRAS G12D Mutant as Potential Therapy in Cancer.,  12  (8.0): [PMID:34413947] [10.1021/acsmedchemlett.1c00390]

Source